Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer

CP Nader, A Cidem, NM Verrills, AJ Ammit - Respiratory Research, 2019 - Springer
Lung cancer (LC) has the highest relative risk of development as a comorbidity of chronic
obstructive pulmonary disease (COPD). The molecular mechanisms that mediate chronic …

The role of MYC and PP2A in the initiation and progression of myeloid leukemias

R Pippa, MD Odero - Cells, 2020 - mdpi.com
The MYC transcription factor is one of the best characterized PP2A substrates. Deregulation
of the MYC oncogene, along with inactivation of PP2A, are two frequent events in cancer …

Anp32a Promotes Neuronal Regeneration after Spinal Cord Injury of Zebrafish Embryos

HC Lee, WL Lai, CY Lin, CW Zeng, JC Sheu… - International Journal of …, 2022 - mdpi.com
After spinal cord injury (SCI) in mammals, neuronal regeneration is limited; in contrast, such
regeneration occurs quickly in zebrafish. Member A of the acidic nuclear phosphoprotein 32 …

Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A …

C Schmelter, KN Fomo, A Brueck, N Perumal… - Biomolecules, 2023 - mdpi.com
Glaucoma is a complex, multifactorial optic neuropathy mainly characterized by the
progressive loss of retinal ganglion cells (RGCs) and their axons, resulting in a decline of …

[HTML][HTML] Acidic leucine-rich nuclear phosphoprotein-32A expression contributes to adverse outcome in acute myeloid leukemia

S Huang, Z Huang, C Ma, L Luo, YF Li… - Annals of …, 2020 - ncbi.nlm.nih.gov
Background Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) is a novel regulator
of histone H3 acetylation and promotes leukemogenesis in acute myeloid leukemia (AML) …

[HTML][HTML] ANP32A Knockdown Attenuates the Malignant Biological Behavior of Colorectal Cancer Cells by Suppressing Epithelial-mesenchymal Transition and ERK …

X Li, X Li, G Liu, L Zhou, Y Liu, T Dou, X Chen… - Journal of …, 2023 - ncbi.nlm.nih.gov
Acidic leucine rich nuclear phosphoprotein-32A (ANP32A) protein has a variety of functions,
such as regulating cell differentiation, influencing cell apoptosis and cell cycle progression …

[HTML][HTML] Small peptide targeting ANP32A as a novel strategy for acute myeloid leukemia therapy

M Wang, H Guo, X Zhang, X Wang, H Tao, T Zhang… - Translational …, 2022 - Elsevier
Clinic therapy of acute myeloid leukemia (AML) remains unsatisfactory that urges for
development of novel strategies. Recent studies identified ANP32A as a novel biomarker of …

Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia

K Qi, X Hu, X Yu, H Cheng, C Wang, S Wang… - Leukemia Research, 2022 - Elsevier
Acute megakaryoblastic leukaemia (AMKL) is characterized by expansion of
megakaryoblasts, which are hyper-proliferative cells that fail to undergo differentiation …

Data mining analysis of the PP2A cell cycle axis in mesothelioma patients

R Pippa, S Boffo, MD Odero… - Journal of Cellular …, 2020 - Wiley Online Library
Mesothelioma is an aggressive tumor that affects thousands of people every year. The
therapeutic options for patients are limited; hence, a better understanding of mesothelioma …

Targeting ANP32A is a novel strategy against leukemia

M Wang, Z Huang - Journal of Clinical Haematology, 2022 - scientificarchives.com
Acute myeloid leukemia (AML) is a type of blood malignancies with high genetic
heterogeneity. Epigenetic alterations including histone acetylation have been found to be …